Literature DB >> 19081538

Molecular and cellular biology of synucleins.

Andrei Surguchov1.   

Abstract

Synucleins are small, soluble proteins expressed primarily in neural tissues and certain tumors. The family includes three known proteins: alpha-synuclein, beta-synuclein, and gamma-synuclein. A typical structural feature of synucleins is the presence of a repetitive, degenerative AA motif KTKEGV throughout the first 87 residues and acidic stretches within the C-terminal region. Members of the synuclein family are natively unfolded proteins that are characterized by a high net charge and low hydropathy. The synuclein family recently came into the spotlight when one of its members, alpha-synuclein, was linked both genetically and neuropathologically to Parkinson's disease. It has a role in other neurodegenerative diseases, such as dementia with Lewy bodies, multiple system atrophy, neurodegeneration with brain iron accumulation type 1, and Alzheimer's disease. Interestingly, another member of the family, beta-synuclein, possesses antagonistic properties to alpha-synuclein. The third member of the family, gamma-synuclein, is implicated in different types of cancer, some neurodegenerative diseases and ocular pathology. The involvement of synuclein proteins in the etiology of common human diseases has raised exciting questions and is currently the subject of intense investigation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19081538     DOI: 10.1016/S1937-6448(08)01406-8

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  31 in total

1.  Profiling of hypothalamic and hippocampal gene expression in chronically stressed rats treated with St. John's wort extract (STW 3-VI) and fluoxetine.

Authors:  Peggy Jungke; Gigi Ostrow; Jian-Liang Li; Sharon Norton; Karen Nieber; Olaf Kelber; Veronika Butterweck
Journal:  Psychopharmacology (Berl)       Date:  2010-10-06       Impact factor: 4.530

Review 2.  GRK2: multiple roles beyond G protein-coupled receptor desensitization.

Authors:  Tama Evron; Tanya L Daigle; Marc G Caron
Journal:  Trends Pharmacol Sci       Date:  2012-01-23       Impact factor: 14.819

3.  Partial regulation of serotonin transporter function by gamma-synuclein.

Authors:  Christophe Wersinger; Anita Sidhu
Journal:  Neurosci Lett       Date:  2009-02-21       Impact factor: 3.046

4.  The reciprocal regulation of gamma-synuclein and IGF-I receptor expression creates a circuit that modulates IGF-I signaling.

Authors:  Minjing Li; Yancun Yin; Hui Hua; Xiangming Sun; Ting Luo; Jiao Wang; Yangfu Jiang
Journal:  J Biol Chem       Date:  2010-07-29       Impact factor: 5.157

Review 5.  G Protein-Coupled Receptor Kinases in the Inflammatory Response and Signaling.

Authors:  Michael D Steury; Laura R McCabe; Narayanan Parameswaran
Journal:  Adv Immunol       Date:  2017-06-10       Impact factor: 3.543

6.  Proteolytic cleavage of extracellular α-synuclein by plasmin: implications for Parkinson disease.

Authors:  Kwang Soo Kim; Yu Ree Choi; Ji-Young Park; Jung-Ho Lee; Dong Kyu Kim; Seung-Jae Lee; Seung R Paik; Ilo Jou; Sang Myun Park
Journal:  J Biol Chem       Date:  2012-05-22       Impact factor: 5.157

7.  Investigation of intramolecular dynamics and conformations of α-, β- and γ-synuclein.

Authors:  Vanessa C Ducas; Elizabeth Rhoades
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

Review 8.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

Review 9.  Proteolytic clearance of extracellular α-synuclein as a new therapeutic approach against Parkinson disease.

Authors:  Sang Myun Park; Kwang Soo Kim
Journal:  Prion       Date:  2012-11-15       Impact factor: 3.931

10.  The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse.

Authors:  Mari H Savolainen; Christopher T Richie; Brandon K Harvey; Pekka T Männistö; Kathleen A Maguire-Zeiss; Timo T Myöhänen
Journal:  Neurobiol Dis       Date:  2014-04-16       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.